These results show how an L. crispatus LBP alters vaginal microbiota composition to improve BV treatment efficacy while identifying factors linked to LBP success that can guide development of future therapies to promote more optimal vaginal microbiota communities and improved women’s health outcomes. The gene discussed is LBP; the disease is bacterial vaginosis.